Advertisement
Advertisement

RLAY

RLAY logo

Relay Therapeutics, Inc. Common Stock

8.91
USD
Sponsored
+0.76
+9.36%
Feb 06, 16:00 UTC -5
Closed
exchange

After-Market

8.89

-0.02
-0.20%

RLAY Earnings Reports

Positive Surprise Ratio

RLAY beat 13 of 22 last estimates.

59%

Next Report

Date of Next Report
Feb 19, 2026
Estimate for Q4 25 (Revenue/ EPS)
$5.06M
/
-$0.41
Implied change from Q3 25 (Revenue/ EPS)
--
/
-4.65%
Implied change from Q4 24 (Revenue/ EPS)
--
/
-8.89%

Relay Therapeutics, Inc. Common Stock earnings per share and revenue

On Nov 06, 2025, RLAY reported earnings of -0.43 USD per share (EPS) for Q3 25, missing the estimate of -0.42 USD, resulting in a -1.46% surprise. Revenue reached --, compared to an expected 186.52 thousand, with a -100.00% difference. The market reacted with a -7.35% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 13 analysts forecast an EPS of -0.41 USD, with revenue projected to reach 5.06 million USD, implying an decrease of -4.65% EPS, and -- of --% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Takeda Pharmaceutical Company Limited - ADR
Report Date
Jan 30, 2026 For Q3 26
Estimate
$34.44
Actual
$65.64
Surprise
+90.61%
FAQ
For Q3 2025, Relay Therapeutics, Inc. Common Stock reported EPS of -$0.43, missing estimates by -1.46%, and revenue of $0.00, -100% below expectations.
The stock price moved down -7.35%, changed from $6.53 before the earnings release to $6.05 the day after.
The next earning report is scheduled for Feb 19, 2026.
Based on 13 analysts, Relay Therapeutics, Inc. Common Stock is expected to report EPS of -$0.41 and revenue of $5.06M for Q4 2025.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement